FDA Approves First PARP Inhibitor as Frontline Maintenance in Pancreatic Cancer
The FDA approved olaparib for the maintenance treatment of adult patients with germline BRCA-mutated metastatic pancreatic adenocarcinoma.
Read more
ADVERTISEMENT
Proven portfolio of tests + services, that’s our Foundation.

Our portfolio of genomic tests & services is designed for cancer patients at any line of therapy, with proven utility for clinical decision making. Rx only; advanced cancer; doesn’t guarantee treatment match. Learn more
 
 
ASTRO Releases Clinical Guideline for Radiation Therapy in Treating Patients with Skin Cancer
The recommendations defined when and how radiation therapy should be used to treat patients with basal cell carcinoma and cutaneous squamous cell carcinoma.
Read more

 
 
Patients with Endometrial Cancer Pose High Risk of Dying from Cardiovascular Disease

Patients with endometrial cancer pose a very high risk of dying from cardiovascular diseases in the year after diagnosis, suggesting the necessity of early involvement of cardiologists for these patients.

Read more